Clinical Trial Update: Efficacy and Safety of Peginesatide (AF37702) in the Treatment of Anemia in Participants With Chronic Kidney Disease [Phase 2]

View source ↗

Summary

Phase 2 trial assessing efficacy and safety of peginesatide (AF37702) for anemia in chronic kidney disease participants completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• Peginesatide (peginesatide)

Snippet

Sponsor: Takeda | Conditions: Anemia, Chronic Kidney Disease | Phase 2 | Status: COMPLETED | Results posted: 2019-03-14